𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The no-observed-adverse-effect-level in drug safety evaluations: Use, issues, and definition(s)

✍ Scribed by Michael A. Dorato; Jeffery A. Engelhardt

Book ID
116991787
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
493 KB
Volume
42
Category
Article
ISSN
0273-2300

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Evaluation of approach to predict the co
Evaluation of approach to predict the contribution of multiple cytochrome P450s in drug metabolism using relative activity factor: Effects of the differences in expression levels of NADPH–cytochrome P450 reductase and cytochrome b5 in the expression system and the differences in the marker activities
✍ Miki Nakajima; Kazuhiro Tane; Sumika Nakamura; Noriaki Shimada; Hiroshi Yamazaki πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 128 KB πŸ‘ 1 views

The concept of relative activity factor (RAF) to extrapolate data obtained with recombinant cytochrome P450(CYP)s to human liver microsomes has been proposed. To evaluate the approach to predict the contribution of multiple CYPs using RAF, we investigated the effects of the differences in the expres